MAPT and Alzheimer disease: The ratio of hippocampus to cortex emerges as the most effective structural MRI (sMRI) biomarker for differentiating between subtypes of AD, aligning with the spatial distribution of tau pathology and predicting the rate of cognitive decline (Krajcovicova et al., 2019).